C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2002
10/29/2002	US6472404 HIV protease inhibitors
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002	US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002	US6472388 Psychotherapeutic agents.
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002	WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002	WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002	WO2002083654A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002	WO2002083653A1 Triazinyl acrylamide derivatives as kinase inhibitors
10/24/2002	WO2002083652A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
10/24/2002	WO2002083650A1 Novel sulfonylamino-pyrimidines
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083127A1 Protein modification-inhibitory compositions
10/24/2002	WO2002083126A1 Phenylindoles for the treatment of hiv
10/24/2002	WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002	WO2002083109A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	WO2002057253A3 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002050057A8 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
10/24/2002	WO2002000650A3 Novel compounds possessing antibacterial, antifungal or antitumor activity
10/24/2002	US20020156292 Anticancer agents
10/24/2002	US20020156119 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
10/24/2002	US20020156115 Pyrazolylacetic acid derivatives
10/24/2002	US20020156114 Antiinflammatory, antiarthritic agents
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156087 Pyrimidine or pyridine derivatives
10/24/2002	US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2443701A1 Triazinyl acrylamide derivatives as kinase inhibitors
10/24/2002	CA2443366A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002	CA2443229A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250326A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1250133A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002	EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002	EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002	CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376149A 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
10/23/2002	CN1376148A Rate-controlled particles
10/23/2002	CN1376147A 吡唑类衍生物 Pyrazole derivatives
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/23/2002	CN1092961C Pharmaceutical with anti-high-blood-sugar
10/22/2002	US6469180 3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1h -pyrrole-2,5,-dione which is substantially free of crystalline compound prepared by dissolving crystalline in a supercritical fluid then evaporating
10/22/2002	US6469179 Dissolving crystalline (bis-indol-3-yl) 3-pyrroline imide derivative in an organic solvent, extracting the solvent with supercritical liquid nitrogen or carbon dioxide
10/22/2002	US6469168 For the treatment of central nervous system disorders, especially anxiety
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002	US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002	US6469037 Prophylactic or therapeutic drug for renal diseases
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469003 Pyridazinone derivatives
10/17/2002	WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002	WO2002081466A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081445A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002080869A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
10/17/2002	WO2002080853A2 Fused heterocyclic inhibitors of factor xa
10/17/2002	WO2002068414A3 Analogs of thalidomide as potential angiogenesis inhibitors
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002	WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002	US20020151724 Such as 1-((4-methoxybenzoyl-D-phenylglycinyl))-4-((isopropylamino)methyl)piperidine hydrochloride as anticoaggulants useful in the treatment of cardiovascular disorders such as thrombosis
10/17/2002	US20020151723 Such as 1-(cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-((2'-(1H-tetrazol-t-yl)biphenyl-4-yl)methyl)benzimidazol-7-carboxylate; exhibits antihypertensive activity and strong angiotensin II antagonistic activity
10/17/2002	US20020151715 Imidazole derivatives
10/17/2002	US20020151575 Heterocyclic topoisomerase poisons
10/17/2002	US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002	CA2444024A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	CA2442904A1 Benzamidine derivative
10/17/2002	CA2442695A1 Indolinones substituted in the 6-position, the preparation thereof and their use as medicaments
10/16/2002	EP1249450A1 Benzimidazole derivatives
10/16/2002	EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002	EP1248770A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
10/16/2002	EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002	EP0944596B1 1-acryloylindoline derivatives and their use as prodrugs of anticancer agents
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374995A Fluorescent maleimides and uses thereof
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
10/16/2002	CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374948A 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same
10/16/2002	CN1374082A Use of glycogen sulphofoenzyme inhibitor

1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 626